Why Cigna Corporation (CI) stock moved
Cigna Corporation (CI) shares rose 0.9% to $283.94 as of July 21, 2026, a slight gain from the prior close of $281.45. BestStocks flagged the session as a material change for CI. Below, we break down what changed for CI, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
CI climbed 0.9% to $283.94
CI rose 0.9% in its latest session, moving from $281.45 to $283.94.
What it means for Cigna Corporation investors
For Cigna Corporation investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive 0.9% session move; Cigna Corporation (CI) moved +3.76% from $293.46 to $304.50 on 2026-07-13, reaching a new 30-day high. Weighing against that: New SEC filing — review for material disclosures; Negative price action. Wall Street's consensus price target sits at $341.82, implying +20.4% upside from $283.94. Over the past 90 days analysts logged 0 upgrades and 2 downgrades. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 9 days out, the next report is the most likely near-term test of the move.
CI price reaction
CI last traded at $283.94, up $2.49 (+0.88%) from the previous close of $281.45. The session traded on 0.8× average volume (below avg), so participation was unremarkable.
Bullish and bearish analyst opinions on Cigna Corporation (CI)
The consensus analyst price target on Cigna Corporation (CI) is $341.82, 20.4% above the recent $283.94. Over the past 90 days analysts logged 0 upgrades, 10 maintains, and 2 downgrades. Here is how the bullish and bearish cases on CI line up.
The bullish case
- Wall Street's consensus price target of $341.82 implies +20.4% upside from $283.94.
- The Street's most bullish target is $400.00 (+40.9%).
- Positive 0.9% session move.
- Cigna Corporation (CI) moved +3.76% from $293.46 to $304.50 on 2026-07-13, reaching a new 30-day high.
- Cigna's Evernorth division announced Pharmacy Forward, an AI-powered specialty pharmacy platform backed by a $100M investment designed to accelerate prescription processing and reduce delays for patients with complex conditions.
The bearish case
- 2 analyst downgrades in the past 90 days, most recently Barclays to Equal Weight (2026-05-26).
- Negative price action.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for CI
Frequently asked questions about CI
Why did Cigna Corporation (CI) stock move?
CI rose 0.9% to $283.94. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did CI stock rise?
CI gained 0.88% ($2.49) versus the prior close of $281.45, last trading at $283.94 on 0.8× average volume.
When is Cigna Corporation's next earnings date?
CI's next earnings report is estimated for 2026-07-30 — about 9 days away.
What is the analyst price target for CI?
The consensus analyst price target for CI is $341.82, about 20.4% above the current $283.94. Over the past 90 days, analysts recorded 0 upgrades, 10 maintains, and 2 downgrades.
How BestStocks tracks CI
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared CI-specific materiality thresholds, triggering an evidence check. It draws on 6 tracked change events for CI, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.